Meta-analysis of the effects of sodium glucose cotransporter 2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes
The co-existence of type 2 diabetes (T2D) and non-alcoholic fatty liver disease (NAFLD) is very common. Delay in the treatment of these conditions can...






